J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 17.68 CNY -6.31% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Joinn Laboratories China Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Joinn Laboratories China Co Ltd
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
J
Joinn Laboratories China Co Ltd
SSE:603127
Cash from Investing Activities
-ÂĄ1B
CAGR 3-Years
16%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash from Investing Activities
-ÂĄ8B
CAGR 3-Years
3%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash from Investing Activities
-ÂĄ1.4B
CAGR 3-Years
26%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash from Investing Activities
-ÂĄ2B
CAGR 3-Years
43%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash from Investing Activities
-ÂĄ5.7B
CAGR 3-Years
-16%
CAGR 5-Years
-77%
CAGR 10-Years
-28%
W
WuXi XDC Cayman Inc
HKEX:2268
Cash from Investing Activities
-ÂĄ91.2m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joinn Laboratories China Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Life Sciences Tools & Services

Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.

Intrinsic Value
17.6 CNY
Fairly Valued
Intrinsic Value
Price
J

See Also

What is Joinn Laboratories China Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1B CNY

Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Cash from Investing Activities amounts to -1B CNY.

What is Joinn Laboratories China Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-46%

Over the last year, the Cash from Investing Activities growth was 19%. The average annual Cash from Investing Activities growth rates for Joinn Laboratories China Co Ltd have been 16% over the past three years , -46% over the past five years .

Back to Top